Does IODIPAMIDE MEGLUMINE Cause Gait inability? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Gait inability have been filed in association with IODIPAMIDE MEGLUMINE. This represents 47.4% of all adverse event reports for IODIPAMIDE MEGLUMINE.
18
Reports of Gait inability with IODIPAMIDE MEGLUMINE
47.4%
of all IODIPAMIDE MEGLUMINE reports
18
Deaths
18
Hospitalizations
How Dangerous Is Gait inability From IODIPAMIDE MEGLUMINE?
Of the 18 reports, 18 (100.0%) resulted in death, 18 (100.0%) required hospitalization, and 18 (100.0%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IODIPAMIDE MEGLUMINE. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does IODIPAMIDE MEGLUMINE Cause?
Off label use (34)
Duodenal ulcer perforation (31)
Hypercholesterolaemia (31)
Blepharospasm (30)
Depression (30)
Epilepsy (30)
Fibromyalgia (30)
Helicobacter infection (30)
Breast cancer stage iii (29)
Dry mouth (29)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)